Metformin and thymoquinone co‐treatment enhance 5‐fluorouracil cytotoxicity by suppressing the PI3K/mTOR/HIF1α pathway and increasing oxidative stress in colon cancer cells

This study investigated the chemotherapeutic effects of 5-fluorouracil (5-FU), metformin (Met), and/or thymoquinone (TQ) single/dual/triple therapies in the HT29, SW480 and SW620 colon cancer (CRC) cell lines. Cell cycle/apoptosis were measured by flow cytometry. The gene and protein expression of apoptosis (PCNA/survivin/BAX/Cytochrome-C/Caspase-3) and cell cycle (CCND1/CCND3/p21/p27) molecules, the PI3K/mTOR/HIF1α oncogenic pathway, and glycolysis regulatory enzymes were measured by quantitative-PCR and Western blot. Markers of oxidative stress were also measured by colorimetric assays. Although all treatments induced anti-cancer effects related to cell cycle arrest and apoptosis, the triple therapy showed the highest pro-apoptotic actions that coincided with the lowest expression of CCND1/CCND3/PCNA/survivin and the maximal increases in p21/p27/BAX/Cytochrome-C/Caspase-3 in all cell lines. The triple therapy also revealed the best suppression of the PI3K/mTOR/HIF1α pathway by increasing its endogenous inhibitors (PTEN/AMPKα) in all cell lines. Moreover, the lowest expression of lactate dehydrogenase and pyruvate dehydrogenase kinase-1 with the highest expression of pyruvate dehydrogenase were seen with the triple therapy, which also showed the highest increases in oxidative stress markers (ROS/RNS/MDA/protein carbonyl groups) alongside the lowest antioxidant levels (GSH/CAT) in all cell lines. In conclusion, this is the first study to reveal enhanced anti-cancer effects for metformin/thymoquinone in CRC that were superior to all monotherapies and the other dual therapies. However, the triple therapy approach showed the best tumoricidal actions related to cell cycle arrest and apoptosis in all cell lines, possibly by enhancing oxidative glycolysis and augmenting oxidative stress through stronger modulation of the PI3K/mTOR/HIF1α oncogenic network.

[1]  B. Mao,et al.  Modulating p-AMPK/mTOR Pathway of Mitochondrial Dysfunction Caused by MTERF1 Abnormal Expression in Colorectal Cancer Cells , 2022, International journal of molecular sciences.

[2]  Ansar Karimian,et al.  The modulatory effects of two bioflavonoids, quercetin and thymoquinone on the expression levels of DNA damage and repair genes in human breast, lung and prostate cancer cell lines. , 2022, Pathology, research and practice.

[3]  Y. Liu,et al.  Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma , 2022, Frontiers in Cell and Developmental Biology.

[4]  Wamidh H. Talib,et al.  Targeting Breast Cancer in Diabetic Mice Using a Combination of Thymoquinone and Metformin , 2022, The Natural Products Journal.

[5]  K. Vukojević,et al.  Metformin and Thymoquinone Synergistically Inhibit Proliferation of Imatinib-Resistant Human Leukemic Cells , 2022, Frontiers in Pharmacology.

[6]  M. Althubiti,et al.  In Vivo and In Vitro Enhanced Tumoricidal Effects of Metformin, Active Vitamin D3, and 5-Fluorouracil Triple Therapy against Colon Cancer by Modulating the PI3K/Akt/PTEN/mTOR Network , 2022, Cancers.

[7]  Saeed M Kabrah,et al.  Enhanced in vitro tumoricidal effects of 5-Fluorouracil, thymoquinone, and active vitamin D3 triple therapy against colon cancer cells by attenuating the PI3K/AKT/mTOR pathway. , 2022, Life sciences.

[8]  S. Karim,et al.  PI3K-AKT Pathway Modulation by Thymoquinone Limits Tumor Growth and Glycolytic Metabolism in Colorectal Cancer , 2022, International journal of molecular sciences.

[9]  W. Zhang,et al.  ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer , 2022, Journal of Experimental & Clinical Cancer Research.

[10]  T. Bradshaw,et al.  Concurrent Reactive Oxygen Species Generation and Aneuploidy Induction Contribute to Thymoquinone Anticancer Activity , 2021, Molecules.

[11]  E. Ranieri,et al.  The Pathogenic Role of PI3K/AKT Pathway in Cancer Onset and Drug Resistance: An Updated Review , 2021, Cancers.

[12]  H. Gali-Muhtasib,et al.  Therapeutic potential of thymoquinone in combination therapy against cancer and cancer stem cells , 2021, World journal of clinical oncology.

[13]  Seung-Hyung Kim,et al.  Coptidis Rhizoma Extract Reverses 5-Fluorouracil Resistance in HCT116 Human Colorectal Cancer Cells via Modulation of Thymidylate Synthase , 2021, Molecules.

[14]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[15]  U. Nir,et al.  Fer and FerT Govern Mitochondrial Susceptibility to Metformin and Hypoxic Stress in Colon and Lung Carcinoma Cells , 2021, Cells.

[16]  J. Skolnick,et al.  Computational Identification of Stearic Acid as a Potential PDK1 Inhibitor and In Vitro Validation of Stearic Acid as Colon Cancer Therapeutic in Combination with 5-Fluorouracil , 2021, Cancer informatics.

[17]  M. Rezaei,et al.  Cytotoxicity of metformin against HT29 colon cancer cells contributes to mitochondrial Sirt3 upregulation , 2020, Journal of biochemical and molecular toxicology.

[18]  M. Uddin,et al.  The Role of Oxidative Stress and Its Counteractive Utility in Colorectal Cancer (CRC) , 2020, Cancers.

[19]  Yurong Song,et al.  PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers , 2020, Cell Death & Disease.

[20]  Danfeng Xue,et al.  Emerging role of NRF2 in ROS-mediated tumor chemoresistance. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[21]  R. Tang,et al.  Metformin Inhibited Proliferation and Metastasis of Colorectal Cancer and presented a Synergistic Effect on 5-FU , 2020, BioMed research international.

[22]  B. Yousefi,et al.  Melatonin increases 5-flurouracil-mediated apoptosis of colorectal cancer cells through enhancing oxidative stress and downregulating survivin and XIAP , 2020, BioImpacts : BI.

[23]  Zhirong Sun,et al.  Fasting inhibits aerobic glycolysis and proliferation in colorectal cancer via the Fdft1-mediated AKT/mTOR/HIF1α pathway suppression , 2020, Nature Communications.

[24]  Surong Zhao,et al.  Metformin enhances the sensitivity of colorectal cancer cells to cisplatin through ROS-mediated PI3K/Akt signaling pathway. , 2020, Gene.

[25]  J. Yun,et al.  AMPKα1 confers survival advantage of colorectal cancer cells under metabolic stress by promoting redox balance through the regulation of glutathione reductase phosphorylation , 2019, Oncogene.

[26]  E. Rozengurt,et al.  Metformin inhibits β-catenin phosphorylation on Ser-552 through an AMPK/PI3K/Akt pathway in colorectal cancer cells. , 2019, The international journal of biochemistry & cell biology.

[27]  N. Cho,et al.  p53 expression status is associated with cancer-specific survival in stage III and high-risk stage II colorectal cancer patients treated with oxaliplatin-based adjuvant chemotherapy , 2019, British Journal of Cancer.

[28]  B. Kim,et al.  Thymoquinone Selectively Kills Hypoxic Renal Cancer Cells by Suppressing HIF-1α-Mediated Glycolysis , 2019, International journal of molecular sciences.

[29]  S. Ganapathy-Kanniappan,et al.  Molecular intricacies of aerobic glycolysis in cancer: current insights into the classic metabolic phenotype , 2018, Critical reviews in biochemistry and molecular biology.

[30]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[31]  L. Roncucci,et al.  Metformin Induces Apoptosis and Alters Cellular Responses to Oxidative Stress in Ht29 Colon Cancer Cells: Preliminary Findings , 2018, International journal of molecular sciences.

[32]  J. Hyun,et al.  Over-activation of AKT signaling leading to 5-Fluorouracil resistance in SNU-C5/5-FU cells , 2018, Oncotarget.

[33]  M. Gariboldi,et al.  Metformin transiently inhibits colorectal cancer cell proliferation as a result of either AMPK activation or increased ROS production , 2017, Scientific Reports.

[34]  V. Dymicka-Piekarska,et al.  Immunohistochemical expression and serum level of survivin protein in colorectal cancer patients. , 2016, Oncology letters.

[35]  A. El-Shemi,et al.  Thymoquinone subdues tumor growth and potentiates the chemopreventive effect of 5-fluorouracil on the early stages of colorectal carcinogenesis in rats , 2016, Drug design, development and therapy.

[36]  B. Zhivotovsky,et al.  5-Fluorouracil-induced RNA stress engages a TRAIL-DISC-dependent apoptosis axis facilitated by p53 , 2015, OncoTarget.

[37]  Chuanhui Xu,et al.  Prognostic Significance of Cyclin D1 Expression in Colorectal Cancer: A Meta-Analysis of Observational Studies , 2014, PloS one.

[38]  G. Sethi,et al.  Thymoquinone Inhibits Tumor Growth and Induces Apoptosis in a Breast Cancer Xenograft Mouse Model: The Role of p38 MAPK and ROS , 2013, PloS one.

[39]  B. Zhivotovsky,et al.  5-Fluorouracil signaling through a calcium–calmodulin-dependent pathway is required for p53 activation and apoptosis in colon carcinoma cells , 2013, Oncogene.

[40]  Michael J. Walker,et al.  A caspase-3 ‘death-switch' in colorectal cancer cells for induced and synchronous tumor apoptosis in vitro and in vivo facilitates the development of minimally invasive cell death biomarkers , 2013, Cell Death and Disease.

[41]  K. Syrjänen,et al.  Expression of Cell Cycle Regulators P21 and P27 as Predictors of Disease Outcome in Colorectal Carcinoma , 2012, Journal of Gastrointestinal Cancer.

[42]  A. Abdel‐Mageed,et al.  Studies on molecular mechanisms of growth inhibitory effects of thymoquinone against prostate cancer cells: role of reactive oxygen species , 2010, Experimental biology and medicine.

[43]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.